Peisheng Hu
- Immunology top 2%
- Immunotherapy and Immune Responses 25
- Immune Cell Function and Interaction 12
- T-cell and B-cell Immunology 7
-
- Monoclonal and Polyclonal Antibodies Research 37
- Radiopharmaceutical Chemistry and Applications 9
- Oncology top 5%
- CAR-T cell therapy research 16
- Biotechnology top 5%
- Immunology and Allergy top 10%
-
- Glycosylation and Glycoproteins Research 11
-
- Virus-based gene therapy research 6
- Co-authors
- Alan L. EpsteinLeslie A. KhawliMelissa G. LechnerJohn R. OhlfestKatherine A. MurphyJason L. HornickTrevor E. AngellKeegan Barry-Holson
- Journals
- Clinical Cancer Research (8 papers)Cancer Biotherapy and Radiopharmaceuticals (6 papers)Journal of Immunotherapy (6 papers)
- Partner nations
- United StatesChina
In The Last Decade
Peisheng Hu
62 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 104
- Immunology 986
- Radiology, Nuclear Medicine and Imaging 697
- Oncology 812
- Biotechnology 132
- Immunology and Allergy 72
Countries citing papers authored by Peisheng Hu
This map shows the geographic impact of Peisheng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peisheng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peisheng Hu more than expected).
Fields of papers citing papers by Peisheng Hu
This network shows the impact of papers produced by Peisheng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peisheng Hu. The network helps show where Peisheng Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peisheng Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 29 | |
| 2 | 2019 | 59 | |
| 3 | 2013 | 268 | |
| 4 | 2012 | 29 | |
| 5 | 2012 | 12 | |
| 6 | 2010 | 38 | |
| 7 | 2010 | 2 | |
| 8 | 2007 | 2 | |
| 9 | 2007 | 7 | |
| 10 | 2007 | 20 | |
| 11 | 2007 | 23 | |
| 12 | 2007 | 21 | |
| 13 | 2006 | 13 | |
| 14 | 2004 | 16 | |
| 15 | 2003 | 29 | |
| 16 | 2003 | 25 | |
| 17 | 2003 | 19 | |
| 18 | 2002 | 22 | |
| 19 | 2002 | 15 | |
| 20 | 1998 | 54 |
About Peisheng Hu
Peisheng Hu is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Oncology, Immunology and Allergy and Genetics, having authored 62 papers that have together received 2.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (37 papers), Immunotherapy and Immune Responses (25 papers), CAR-T cell therapy research (16 papers), Immune Cell Function and Interaction (12 papers), Glycosylation and Glycoproteins Research (11 papers), Radiopharmaceutical Chemistry and Applications (9 papers), T-cell and B-cell Immunology (7 papers) and Virus-based gene therapy research (6 papers). The work is most often cited by research in Immunology (986 citations), Radiology, Nuclear Medicine and Imaging (697 citations), Oncology (812 citations), Biotechnology (132 citations) and Immunology and Allergy (72 citations). Peisheng Hu has collaborated with scholars based in United States and China. Frequent co-authors include Alan L. Epstein, Leslie A. Khawli, Melissa G. Lechner, John R. Ohlfest, Katherine A. Murphy, Jason L. Hornick, Trevor E. Angell, Keegan Barry-Holson, Connor H. Church and Jiali Li. Their work appears in journals such as Clinical Cancer Research, Cancer Biotherapy and Radiopharmaceuticals, Journal of Immunotherapy, Blood and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.